Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mitchell Sanders
AddedMar 31, 2024
UpdatedMay 31, 2026
Mitchell Sanders

Mitchell Sanders

Founder, Boynton Angels

CrunchbaseLinkedIn

Mitchell Sanders's Career

Boynton Angels
Boynton Angels

Westborough, MA, US

Founder
ECI Biotech
ECI Biotech

Worcester, MA, US

Founder & CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mitchell Sanders's Career

Boynton Angels
Boynton Angels
Investment FirmInvestment Firm62006Westborough, MA, US
Founder

Similar to Boynton Angels

Phenomenelle AngelsPhenomenelle AngelsMadison, WI, USPhenomenelle AngelsMadison, WI, US

Phenomenelle Angels, LLC: A global investment firm focusing on women and minority-led businesses across various sectors.

Investment Firm30
Angel InvestorAngel InvestorPalo Alto, CA, USest. 2020Angel InvestorPalo Alto, CA, US · est. 2020

Palo Alto-based financial firm specializing in impactful angel investments in startups.

Investment Firm105
FP AngelsFP AngelsWilmington, DE, USest. 2013FP AngelsWilmington, DE, US · est. 2013

FP Angels: A nationwide investment firm specializing in seed and early-stage companies.

Investment Firm6
Pointe AngelsPointe AngelsGrosse Pointe, MI, USest. 2019Pointe AngelsGrosse Pointe, MI, US · est. 2019

Pointe Angels: An investor club offering significant capital returns on early-stage enterprise investments.

Investment Firm375
ECI Biotech
ECI Biotech
Pre-Seed$3.4M301998Worcester, MA, US
Founder & CEO· C-Suite · Management

Leadership at ECI Biotech

Geert CauwenberghGeert CauwenberghBoard Member

Similar to ECI Biotech

OmniVisOmniVisSouth San Francisco, CA, USDiagnostics, Pathogen Detectionest. 2017OmniVisSouth San Francisco, CA, US · est. 2017

OmniVis: A leading biotech startup revolutionizing pathogen detection with fast, accurate, and affordable handheld devices.

Series A · $3.5M5
PhageTechPhageTechIrvine, CA, USDisease Detectionest. 2014PhageTechIrvine, CA, US · est. 2014

PhageTech Inc: Innovating early disease detection through bacteriophage substrate sensors.

Series A · $2.4M11
Innovative BiosensorsInnovative BiosensorsRockville, MD, USBioassays, Biosensorsest. 2003Innovative BiosensorsRockville, MD, US · est. 2003

Provider of innovative, rapid biosensor technology for cost-effective, on-site bioassays with high sensitivity and specificity.

Seed · $20.2M11
EDP BiotechEDP BiotechKnoxville, TN, USMedical Devicesest. 2005EDP BiotechKnoxville, TN, US · est. 2005

EDP Biotech: Specializing in early-detection biomarker development, diagnostics, and patient testing in Tennessee.

Angel · $2.7M27

Mitchell Sanders's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuChi-hyung SongChi-hyung SongCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver Financial

People Similar to Mitchell Sanders

Jorge CordovaJorge CordovaCo-Founder · Synterna TechnologiesBinny MathewsBinny MathewsCo-Founder & CEO · ProjectProCamilo CruzCamilo CruzFounder & CEO · ProximaBrodie YastrumBrodie YastrumCo-Founder · RepleniumTom AndersonTom AndersonCEO · DevvioBenjamin CohenBenjamin CohenFounder & CEO · Proton